Hindustan Bio Sciences Limited announced unaudited earnings results for the second quarter and half year ended September 30, 2018. For the quarter, the company reported revenue from operations of INR 14.739 million as compared to INR 0.736 million a year ago. Profit before Exceptional and Extraordinary items and tax was INR 0.233 million as compared to loss before Exceptional and Extraordinary items and tax of INR 0.625 million a year ago. Profit before tax was INR 0.233 million as compared to loss before tax of INR 0.625 million a year ago. Profit for the period was INR 0.233 million as compared to loss for the period of INR 0.625 million a year ago. Diluted and basic earnings per share were INR 0.02 as compared to diluted and basic loss per share of INR 0.06 a year ago. Profit from continuing operations was INR 0.233 million or INR 0.02 per basic and diluted share as compared to loss from continuing operations of INR 0.625 million or INR 0.06 per basic and diluted share a year ago. For the six months, the company reported revenue from operations of INR 20.626 million as compared to INR 0.736 million a year ago. Profit before Exceptional and Extraordinary items and tax was INR 0.215 million as compared to loss before Exceptional and Extraordinary items and tax of INR 1.777 million a year ago. Profit before tax was INR 0.215 million as compared to loss before tax of INR 1.777 million a year ago. Profit for the period was INR 0.215 million as compared to loss for the period of INR 1.777 million a year ago. Diluted and basic earnings per share were INR 0.02 as compared to diluted and basic loss per share of INR 0.17 a year ago. Profit from continuing operations was INR 0.215 million or INR 0.02 per basic and diluted share as compared to loss from continuing operations of INR 1.777 million or INR 0.17per basic and diluted share a year ago.